Skip to main content
. 2021 Jan 7;31:100621. doi: 10.1016/j.eclinm.2020.100621

Table 3.

Distribution of ART initiation and HIV-related outcome for those with and without depression, and those with and without anxiety.

Characteristic, N (%) Total (N = 2319) Depression
Anxiety
No (N = 2028) Yes (N = 291) p No (N = 2103) Yes (N = 216) p
Linkage to care (ART initiation within 3 months) 1707 (73.6) 1514 (74.7) 193 (66.3) <0.01 1553 (73.8) 154 (71.3) 0.46
ART Initiation by 12 months 1945 (83.9) 1709 (87.9) 236 (81.1) 0.19 1759 (83.6) 186 (86.1) 0.39
Missed refills (N = 1858) 414 (22.3) 372 (22.7) 42 (19.1) 0.25 378 (22.5) 36 (20.5) 0.31
Missed visits (N = 2312) 735 (31.8) 676 (33.4) 59 (20.3) <0.01 686 (32.7) 49 (22.7) <0.01
Retention in care at 12 months 1543 (66.6) 1362 (67.2) 181 (62.2) 0.1 1403 (66.7) 140 (64.8) 0.62
Lost to follow-up 455 (19.6) 395 (19.5) 60 (20.6) 0.7 416 (19.8) 39 (18.1) 0.6
CD4 count1, mean (SD) −16.6 (102.3) −11.6 (92.3) −51.4 (150.9) <0.01 −13.4 (95.8) −48.6 (148.8) <0.01
Viral load2 (end), mean (SD) 5.6 (2.2) 5.6 (2.2) 5.4 (1.8) 0.14 5.6 (2.2) 5.5 (1.9) 0.39
Hospitalization or death 172 (7.4) 145 (7.1) 27 (9.3) 0.23 152 (7.2) 20 (9.3) 0.34

T-test significance testing for CD4 count and viral load; Chi-Square significance testing for linkage to care, ART initiation, missed refills and visits, retention in care, lost to follow-up, and hospitalization or death.

ART: antiretroviral therapy, SD: standard deviation.

1

Change from baseline to last CD4 reading.

2

Log-transformed viral load.